These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23958455)

  • 1. Open innovation and intellectual property: time for a reboot?
    Judd DB
    Drug Discov Today; 2013 Oct; 18(19-20):907-9. PubMed ID: 23958455
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicine. Can intellectual property save drug development?
    FitzGerald GA
    Science; 2012 Oct; 338(6106):483-4. PubMed ID: 23112323
    [No Abstract]   [Full Text] [Related]  

  • 3. Sources of innovation: an assessment of intellectual property.
    Kinch MS; Raffo J
    Drug Discov Today; 2015 May; 20(5):500-4. PubMed ID: 25499663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinventing bioinnovation.
    Kaitin KI; Honig PK
    Clin Pharmacol Ther; 2013 Sep; 94(3):279-83. PubMed ID: 23963211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can open-source drug R&D repower pharmaceutical innovation?
    Munos B
    Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Open innovation for pharmaceutical industries].
    Matsumoto Y; Sakata T
    Nihon Yakurigaku Zasshi; 2013 Apr; 141(4):199-204. PubMed ID: 23575425
    [No Abstract]   [Full Text] [Related]  

  • 7. China spurs pharma innovation.
    Hughes B
    Nat Rev Drug Discov; 2010 Aug; 9(8):581-2. PubMed ID: 20671751
    [No Abstract]   [Full Text] [Related]  

  • 8. [Strategic construction of an innovative drug development pipeline by industry-academia cooperation - consortium for drug innovation in the Tokai region of Japan].
    Akaike A
    Nihon Yakurigaku Zasshi; 2014 May; 143(5):254-9. PubMed ID: 24813797
    [No Abstract]   [Full Text] [Related]  

  • 9. Pediatric drug development.
    Walson PD
    Clin Ther; 2014 Feb; 36(2):154-5. PubMed ID: 24529286
    [No Abstract]   [Full Text] [Related]  

  • 10. Panning for gold: sourcing pharmaceutical innovation.
    Cha M; Saxena A; Smietana K; Bansal R
    Nat Rev Drug Discov; 2015 Jun; 14(6):376. PubMed ID: 26000724
    [No Abstract]   [Full Text] [Related]  

  • 11. [Research, intellectual property and development. Its implications for Argentine science].
    Gómez DE
    Medicina (B Aires); 2015; 75(1):62-4. PubMed ID: 25637906
    [No Abstract]   [Full Text] [Related]  

  • 12. Patent-free pact pushes the boundaries of precompetitive research.
    Dolgin E
    Nat Med; 2014 Jun; 20(6):564-5. PubMed ID: 24901552
    [No Abstract]   [Full Text] [Related]  

  • 13. Catalyzing the Critical Path Initiative: FDA's progress in drug development activities.
    Parekh A; Buckman-Garner S; McCune S; ONeill R; Geanacopoulos M; Amur S; Clingman C; Barratt R; Rocca M; Hills I; Woodcock J
    Clin Pharmacol Ther; 2015 Mar; 97(3):221-33. PubMed ID: 25670629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open innovation: share or die..
    Talaga P
    Drug Discov Today; 2009 Nov; 14(21-22):1003-5. PubMed ID: 19778629
    [No Abstract]   [Full Text] [Related]  

  • 15. Waiving intellectual property rights: Boom or bust for medical innovation?
    Rake B
    Drug Discov Today; 2022 Feb; 27(2):384-389. PubMed ID: 34718204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Industry and regulatory performance in 2012: a year in review.
    Dowden HM; Jahn R; Catka T; Jonsson A; Michael E; Miwa Y; Zinkand W
    Clin Pharmacol Ther; 2013 Sep; 94(3):359-66. PubMed ID: 23657160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways across the valley of death: novel intellectual property strategies for accelerated drug discovery.
    Rai AK; Reichman JH; Uhlir PF; Crossman C
    Yale J Health Policy Law Ethics; 2008; 8(1):1-36. PubMed ID: 18564492
    [No Abstract]   [Full Text] [Related]  

  • 18. Fine print TRIPS up multinational and Indian companies.
    Frantz S
    Nat Rev Drug Discov; 2005 Feb; 4(2):94-5. PubMed ID: 15759327
    [No Abstract]   [Full Text] [Related]  

  • 19. Intellectual property protection: strategies for antibody inventions.
    Storz U
    MAbs; 2011; 3(3):310-7. PubMed ID: 21494091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Innovative Medicines Initiative: an engine for regulatory science.
    Goldman M; Seigneuret N; Eichler HG
    Nat Rev Drug Discov; 2015 Jan; 14(1):1-2. PubMed ID: 25503331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.